Latest Business and People News
Updated employee announcements, business news, awards and recognition in the industry today.
People News
Global health science marketing and communications firm SCORR Marketing announced the addition of three employees-Lea LaFerla, vice president of marketing services; Edlyn Tobias, marketing technology manager; and James Wang, associate director of business development.
teckro, a global life sciences mobile technology company, announced that Ashley Parish has been appointed vice president, strategic alliances. Parish has 19 years of experience working in strategic business development for clinical research technology companies.
Certara® announced that Professor Jennifer B. Dressman, PhD, has been appointed to the Simcyp® Scientific Advisory Board (SAB). Dressman is Professor of Pharmaceutical Technology and Director of the Institute of Pharmaceutical Technology at the Johann Wolfgang Goethe University in Frankfurt, Germany.
Business News
Frenova Renal Research, a drug and medical device contract clinical development services provider dedicated to renal research, announced that its F1RST Up™ alliance of clinical research sites that focuses on kidney disease has expanded to include 55 physician investigators representing 23 sites.
INC Research Holdings, Inc., a global Phase I to IV CRO, announced the expansion and relocation of its Tokyo, Japan office. The new office is located at 27F Shinagawa Season Terrace, 1-2-70 Konan, Minato-ku, Tokyo.
Certara®, a global model-informed drug development and regulatory science company, announced it has endowed a professorship at the University of Florida College of Pharmacy’s Center for Pharmacometrics and Systems Pharmacology.
The Center for Information and Study on Clinical Research Participation (CISCRP), an independent, non-profit organization dedicated to educating patients and the public about clinical research, recognizes WIRB-Copernicus Group® (WCG) for its recent support of CISCRP’s Medical Heroes 5K Run & Walk, held in Chicago in June, and its additional donation to CISCRP’s clinical research education and outreach programs.
PAREXEL International, a global biopharmaceutical services provider, announced that the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer Gold Standard™ employer. The biennial U.S.-based accreditation, which PAREXEL previously received in 2015, recognizes the Company’s strong commitment to the health of its employees and their families.
CRO, Rho, participated in the 10th annual Smile Train Triathlon as Title Sponsor. CEO Russ Helms has participated the last eight years to support a cause that is close to his heart-both he and his daughter were born with cleft lip and palate. The triathlon consisted of a 250 meter pool swim, 12 mile bike ride, and a 3.1 mile run.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
